Latest News

The expanded role is expected to strengthen referral services across Western Kenya and the wider East African region while reducing pressure on national referral hospitals.

DeepHealth Breast Ultrasound automates several stages of breast ultrasound examinations, including lesion detection, characterisation and reporting.

CereVasc designed the facility to meet the company’s expected operational needs as it advances the eShunt System towards potential commercialisation.

The divestment forms part of the company’s broader restructuring as it seeks to strengthen its finances and sharpen its focus on higher-value healthcare products.

The latest milestone advances the company’s second clinical-stage therapeutic candidate and marks the first clinical programme built using its proprietary Au-HALO™ liver-targeting delivery technology and siRNA platform.

IMPACT Therapeutics received approval from China’s National Medical Products Administration (NMPA) in January 2025 for senaparib as a first-line maintenance therapy for adults with advanced ovarian, fallopian tube, or primary peritoneal cancer.

The survey will involve about 10,000 pregnant women across all 10 regions of Cameroon.

AbCellera will oversee discovery and early-stage development activities, while Vertex will finance all research and development costs.

Amylyx developed the education initiative after researching the PBH patient community.

The findings will inform a continental report intended to support evidence-based policymaking, strengthen accountability and accelerate efforts to prevent maternal and newborn deaths across Africa.